✦ LIBER ✦

Diuretic and antihypertensive effects of Sinorphan, an orally active inhibitor of atriopeptidase (EC 3.4.24.11)

✍ Scribed by C. Mossiat; J. Bralet; C. Gros; J.C. Schwartz; J.M. Lecomte

Book ID: 115985295
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 100 KB
Volume: 24
Category: Article
ISSN: 0022-2828
DOI: 10.1016/0022-2828(92)93263-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemodynamic and antihypertensive effects

Hemodynamic and antihypertensive effects of SQ 14,225, an orally active converting enzyme inhibitor

📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 211 KB

UK-69, 578, a novel inhibitor of EC 3.4.

UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic

✍ J.C. Danilewicz; P.L. Barclay; I.T. Barnish; D. Brown; S.F. Campbell; K. James; 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 437 KB

Chronic antihypertensive effects of capt

Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats

✍ Bernard Rubin; Michael J. Antonaccio; Morton E. Goldberg; Don N. Harris; Arthur 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 886 KB

Evaluation of the effect of hypoxia on t

Evaluation of the effect of hypoxia on the expression and activity of neprilysin (EC 3.4.24.11), a protease involved on Alzheimer’s disease

✍ Watanabe De Oliveira, R.; Silva Julian, G.; Cini Perry, J.; Tufik, S.; Visniausk 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Structural Characterization and Pharmaco

Structural Characterization and Pharmacodynamic Effects of an Orally Active 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor

✍ Clarence Hale; Murielle Véniant; Zhulun Wang; Michelle Chen; Jocelyn McCormick; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

Anti-tumour/metastasis effects of the po

Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: An orally active anti-cancer drug waiting for its call-of-duty?

✍ Hayden Matthews; Marie Ranson; Michael J. Kelso 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 467 KB

## Abstract Amiloride.HCl is clinically used as an oral potassium‐sparing diuretic, but multiple studies in biochemical, cellular and animal models have shown that the drug also possesses anti‐tumour and anti‐metastasis activities. The additional effects appear to arise through inhibition of two di